Paleo Versus Healthy ADA Diets for Treatment of Polycystic Ovarian Syndrome (PCOS)
PALEOLITHIC VS Healthy ADA DIETS FOR TREATMENT OF POLYCYSTIC OVARIAN SYNDROME (PCOS)
1 other identifier
interventional
15
1 country
1
Brief Summary
Polycystic ovary syndrome (PCOS) is a syndrome which includes elevated androgen levels, irregular menstrual cycles and insulin resistance. Standard treatments, which include weight loss and medications to improve insulin secretion are only partly successful, and may require that young women take medications for decades. The study investigators have been evaluating the effects of specific diets on insulin resistance in healthy volunteers and subjects with type 2 diabetes, and have found that subjects with insulin resistance seem to respond particularly well to these diet regimens. Volunteers with PCOS are being asked to participate to see if following these diets can help regularize your menstrual cycles. The results of this study may help improve fertility treatments for women with PCOS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 20, 2014
CompletedFirst Posted
Study publicly available on registry
July 15, 2014
CompletedStudy Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 29, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 29, 2022
CompletedDecember 1, 2022
November 1, 2022
7.6 years
June 20, 2014
November 30, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
menstrual cycle frequency
questionnaires, ovarian ultrasound for volume
4 months
Secondary Outcomes (1)
insulin sensitivity
4 months
Study Arms (2)
paleolithic diet
EXPERIMENTALsubjects in this arm are given detailed instructions and coaching in following a paleolithic type diet for 4 months, with the option to continue for another 4 months. studies of ovarian and metabolic parameters will be done at baseline, 2 and 4 months
American Diabetes Association diet
ACTIVE COMPARATORsubjects in this arm are given detailed instructions and coaching in following an ADA type diet for 4 months, with the option to switch over to the paleolithic diet arm for another 4 months. studies of ovarian and metabolic parameters will be done at baseline, 2 and 4 months
Interventions
Eligibility Criteria
You may qualify if:
- Chronic oligo/anovulation defined as an intermenstrual interval of \>45 days and/or \< 8 menstrual cycles/year and evidence of either hyperandrogenemia (elevation of total or free testosterone above the normal range for women) and/or clinical hyperandrogenism (hirsutism and/or acne)
- Age 18-40
- Agreeable to avoidance of pregnancy and to use barrier contraception for duration of study
- BMI between 18 to 40 kg/m2
You may not qualify if:
- Other abnormalities which might lead to anovulation: hyperprolactinemia, thyroid dysfunction and other causes of hyperandrogenemia including late onset congenital hyperplasia
- Evidence of diabetes based on a fasting glucose \>126 mg/dl or OGTT
- Use of medications and/or supplements that influence either ovarian function or insulin sensitivity, within 2 months: including oral contraceptive pills, hormonal implants, anti-androgens, antipsychotics or antihypertensives metformin, glucocorticoids, and/or health food remedies other than multi-vitamins and calcium;
- Subjects who are on oral contraception, metformin, or nutritional supplements must agree to discontinue these drugs and undergo an 8 week washout period before the tests are performed
- Alcohol usage more than 7 drinks/week
- Hemoglobin \< 10 grams
- Smokers
- Inability to understand the study goals and protocols and the consent form
- Any subject, who in the opinion of the investigators, does not qualify for the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UCSF
San Francisco, California, 94143, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Heather Huddleston, MD
University of California, San Francisco
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 20, 2014
First Posted
July 15, 2014
Study Start
January 1, 2015
Primary Completion
July 29, 2022
Study Completion
August 29, 2022
Last Updated
December 1, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share
would share only with participant, if asked by participant